标题
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
作者
关键词
-
出版物
MOLECULES
Volume 26, Issue 14, Pages 4250
出版商
MDPI AG
发表日期
2021-07-14
DOI
10.3390/molecules26144250
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton
- (2021) Muhamad Mustafa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, Synthesis, Biological Evaluation, and Molecular Docking of 2,4-Diaminopyrimidine Derivatives Targeting Focal Adhesion Kinase as Tumor Radiotracers
- (2021) Yueheng Qi et al. MOLECULAR PHARMACEUTICS
- Benzopyrimidodiazepinone inhibitors of TNK2
- (2020) Brian J. Groendyke et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bifunctional Pyrimidines as Modulators of Focal Adhesion Kinase
- (2020) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Chemically Induced Degradation of FAK-ALK for Application in Cancer Therapeutics
- (2020) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Design, synthesis, and biological evaluation of F-18-labelled 2, 4-diaminopyrimidine-type FAK-targeted inhibitors as potential tumour imaging agents
- (2020) Yueheng Qi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
- (2020) Yang Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor
- (2020) Brian J. Groendyke et al. ACS Medicinal Chemistry Letters
- Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions
- (2019) Johannes Popow et al. JOURNAL OF MEDICINAL CHEMISTRY
- A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
- (2019) Gabriel Mak et al. BRITISH JOURNAL OF CANCER
- Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells
- (2019) Luhong Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities
- (2019) Yue Su et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK)
- (2019) Xiaotian Kong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells
- (2019) Jian Song et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of diphenylpyrimidine derivatives (DPPYs) as potential dual EGFR T790M and FAK inhibitors against a diverse range of cancer cell lines
- (2019) Min Ai et al. BIOORGANIC CHEMISTRY
- Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs
- (2019) Hongying Gao et al. ACS Medicinal Chemistry Letters
- Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents
- (2019) Ruifeng Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors
- (2019) Ruifeng Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
- (2019) David E. Gerber et al. LUNG CANCER
- Structure-Based Design, Synthesis, and Characterization of the First Irreversible Inhibitor of Focal Adhesion Kinase
- (2018) Expédite Yen-Pon et al. ACS Chemical Biology
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors
- (2018) Mehlika Dilek Altıntop et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Study of the Focal Adhesion Kinase Inhibitor GSK2256098 in Patients with Recurrent Glioblastoma with Evaluation of Tumor Penetration of [11C]GSK2256098
- (2018) Nicholas F Brown et al. NEURO-ONCOLOGY
- VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
- (2018) Ning Ji et al. Frontiers in Pharmacology
- Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers
- (2017) Dong-Jun Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways
- (2017) Dong-Jun Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural optimization of diphenylpyrimidine derivatives (DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B leukemia cell lines
- (2017) Dan Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia
- (2017) He Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reply to Letter to the Editor “Concern on article “Predicting procedure successful rate and 1-year patency after endovascular recanalization for chronic carotid artery occlusion by CT angiography””
- (2017) Hon-Man Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Chemical Structure Characteristics and Bioactivity of Small Molecule FAK Inhibitors
- (2016) Fang-Yuan Cao et al. Anti-Cancer Agents in Medicinal Chemistry
- Phosphonate-based irreversible inhibitors of human γ-glutamyl transpeptidase (GGT). GGsTop is a non-toxic and highly selective inhibitor with critical electrostatic interaction with an active-site residue Lys562 for enhanced inhibitory activity
- (2016) Akane Kamiyama et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency
- (2016) Julie Farand et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and antiproliferative activity studies of novel dithiocarbamate–chalcone derivates
- (2016) Dong-Jun Fu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
- (2016) Toshio Shimizu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)
- (2016) Gregory R. Ott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase
- (2016) Wei-Sheng Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- Discovery of Novel Bruton’s Tyrosine Kinase (BTK) Inhibitors Bearing a N,9-Diphenyl-9H-purin-2-amine Scaffold
- (2016) Yang Ge et al. ACS Medicinal Chemistry Letters
- Designed to Kill: Novel Menin-MLL Inhibitors Target MLL -Rearranged Leukemia
- (2015) Michael W.M. Kühn et al. CANCER CELL
- Evaluating reaction pathways of hydrothermal abiotic organic synthesis at elevated temperatures and pressures using carbon isotopes
- (2015) Qi Fu et al. GEOCHIMICA ET COSMOCHIMICA ACTA
- Targeting FAK scaffold functions inhibits human renal cell carcinoma growth
- (2015) Claire Béraud et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- FAK signaling in human cancer as a target for therapeutics
- (2015) Brian Y. Lee et al. PHARMACOLOGY & THERAPEUTICS
- Emerging Roles of Focal Adhesion Kinase in Cancer
- (2015) Yu-Ling Tai et al. Biomed Research International
- Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance
- (2015) Robert M. Jotte et al. Cancer Medicine
- Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity
- (2014) Yong-Tao Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PND-1186 FAK inhibitor selectively promotes tumore cell apoptosis in three-dimensional environments
- (2014) Michael D. Schaller et al. CANCER BIOLOGY & THERAPY
- Focal adhesion kinase
- (2014) Rebecca L Stone et al. CANCER BIOLOGY & THERAPY
- A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells
- (2014) Jianliang Zhang et al. CELL CYCLE
- Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review
- (2014) Ekambaram Shanthi et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Design, Synthesis, and Evaluation of Novel Imidazo[1,2-a][1,3,5]triazines and Their Derivatives as Focal Adhesion Kinase Inhibitors with Antitumor Activity
- (2014) Pascal Dao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases
- (2014) Zilan Song et al. JOURNAL OF MEDICINAL CHEMISTRY
- A New Challenging and Promising Era of Tyrosine Kinase Inhibitors
- (2014) J. Jean Cui ACS Medicinal Chemistry Letters
- Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity
- (2013) Pascal Dao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure-based discovery of cellular-active allosteric inhibitors of FAK
- (2013) Naoki Tomita et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
- (2013) B. D. Crompton et al. CANCER RESEARCH
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- Irreversible kinase inhibitors gain traction
- (2013) Katharine Sanderson NATURE REVIEWS DRUG DISCOVERY
- Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
- (2012) Alexander Schultze et al. Anti-Cancer Agents in Medicinal Chemistry
- Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents
- (2012) Xian-Hui Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 2-Anilino-4-(benzimidazol-2-yl)pyrimidines – A multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines
- (2012) Renate Determann et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking
- (2012) Fengbo Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FAK promotes recruitment of talin to nascent adhesions to control cell motility
- (2012) Christine Lawson et al. JOURNAL OF CELL BIOLOGY
- Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors
- (2012) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
- (2012) Tjeerd Barf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT
- (2012) Y Zheng et al. ONCOGENE
- In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression
- (2012) Pablo Rosado et al. VIRCHOWS ARCHIV
- Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents
- (2011) Juan Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
- (2011) Craig A. Zificsak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prodrugs - An Efficient Way to Breach Delivery and Targeting Barriers
- (2011) Kristiina M. Huttunen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Focal adhesion kinase and tumour angiogenesis
- (2011) Tanguy Lechertier et al. JOURNAL OF PATHOLOGY
- Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
- (2011) J. B. Stokes et al. MOLECULAR CANCER THERAPEUTICS
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Tuning protein autoinhibition by domain destabilization
- (2011) Jae-Hyun Cho et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors
- (2010) Roberto T. Bossi et al. BIOCHEMISTRY
- Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
- (2010) Cedo M Bagi et al. CANCER BIOLOGY & THERAPY
- PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments
- (2010) Isabelle Tanjoni et al. CANCER BIOLOGY & THERAPY
- Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer
- (2010) Alexander Schultze et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chemical Inducers of Targeted Protein Degradation
- (2010) Kanak Raina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
- (2010) M. D. Schaller JOURNAL OF CELL SCIENCE
- The FERM domain: organizing the structure and function of FAK
- (2010) Margaret C. Frame et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity
- (2010) Gregory R. Ott et al. ACS Medicinal Chemistry Letters
- Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents
- (2009) Myung Yun Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Signal transduction by focal adhesion kinase in cancer
- (2009) Jihe Zhao et al. CANCER AND METASTASIS REVIEWS
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling
- (2009) Yuliya Pylayeva et al. JOURNAL OF CLINICAL INVESTIGATION
- Progress in researches about focal adhesion kinase ingastrointestinal tract
- (2009) Hui Fang Hao et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
- (2008) W. G. Roberts et al. CANCER RESEARCH
- Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities
- (2008) Ahmet Demirbas et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
- Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation
- (2008) Daniel Lietha et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now